| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 19,360 | $31.97 | $618,948.88 | -6.8% | -2.4% | -30.9% | |
| May 4, 2021 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 3,305 | $340.01 | $1,123,718.18 | -18.2% | +19.7% | -24.0% | |
| May 4, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 2,702 | $117.39 | $317,187.78 | -6.0% | +3.4% | -69.3% | |
| May 3, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 20,000 | $76.64 | $1,532,722.77 | -2.4% | +6.4% | -57.6% | |
| May 3, 2021 | VCYT Veracyte, Inc. | Eastham Karin65 | Director | Sell | 4,427 | $48.27 | $213,699.64 | -13.8% | -4.5% | -53.3% | |
| May 3, 2021 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 19,240 | $131.09 | $2,522,171.60 | -2.5% | -13.6% | -55.3% | |
| Apr 28, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 14,374 | $68.48 | $984,311.96 | -0.8% | -7.8% | -66.6% | |
| Apr 27, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 40,000 | $31.47 | $1,258,800.00 | -13.1% | +3.4% | -30.8% | |
| Apr 27, 2021 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 17,169 | $258.76 | $4,442,633.27 | -16.9% | +12.6% | -1.9% | |
| Apr 27, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 28,748 | $70.02 | $2,012,979.77 | -1.0% | -6.8% | -67.8% | |
| Apr 26, 2021 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $159.92 | $86,036.96 | -10.4% | -32.5% | -60.1% | |
| Apr 26, 2021 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 19,878 | $137.40 | $2,731,335.83 | -0.5% | -18.2% | -77.7% | |
| Apr 26, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 28,534 | $192.59 | $5,495,504.57 | -0.2% | -6.6% | -31.8% | |
| Apr 26, 2021 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 8,139 | $160.11 | $1,303,160.22 | -0.2% | -32.5% | -60.1% | |
| Apr 26, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 28,534 | $192.59 | $5,495,504.57 | -0.2% | -6.6% | -31.8% | |
| Apr 26, 2021 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 264 | $135.60 | $35,798.40 | -1.2% | -18.2% | -77.7% | |
| Apr 23, 2021 | DHR Danaher Corp /de/ | Ellis Brian W62 | SVP &General Counsel | Sell | 13,277 | $254.91 | $3,384,487.60 | -16.7% | +11.3% | +2.1% | |
| Apr 23, 2021 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 3,092 | $255.79 | $790,902.68 | -9.1% | +11.3% | +2.1% | |
| Apr 23, 2021 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 500 | $137.00 | $68,500.00 | -0.9% | +10.1% | -10.8% | |
| Apr 22, 2021 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 3,845 | $330.00 | $1,268,850.00 | -20.6% | +17.7% | -16.7% | |
| Apr 22, 2021 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 9,053 | $135.00 | $1,222,155.00 | -3.4% | +10.9% | -9.3% | |
| Apr 22, 2021 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 5,000 | $133.47 | $667,350.00 | -9.4% | -8.6% | -74.6% | |
| Apr 22, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,213 | $110.14 | $353,869.54 | -3.5% | +9.5% | -66.1% | |
| Apr 22, 2021 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 15,000 | $63.69 | $955,294.45 | -0.6% | +4.9% | -65.0% | |
| Apr 22, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 30,064 | $187.79 | $5,645,860.02 | -0.2% | -2.7% | -19.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.